NHS to treat young cancer patients with expensive 'game changer' drug Chief executive to announce use of CAR-T therapy drug Kymriah, which costs £282,000 per patient
The NHS is to treat children and young people with an expensive new cancer drug which has the potential to transform how the disease is treated.
Simon Stevens, the NHS England chief executive, will announce on Wednesday that a deal has been done with the drug company Novartis, which makes the immunotherapy drug under the name Kymriah. Continue reading... The Guardian
No comments:
Post a Comment